Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) EBT Margin (2016 - 2025)

Historic EBT Margin for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to 332.97%.

  • Editas Medicine's EBT Margin rose 1015293200.0% to 332.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 426.12%, marking a year-over-year decrease of 851800.0%. This contributed to the annual value of 733.71% for FY2024, which is 5396300.0% down from last year.
  • As of Q3 2025, Editas Medicine's EBT Margin stood at 332.97%, which was up 1015293200.0% from 1438.71% recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's EBT Margin registered a high of 31.41% during Q4 2023, and its lowest value of 132683.33% during Q3 2022.
  • Over the past 5 years, Editas Medicine's median EBT Margin value was 873.2% (recorded in 2021), while the average stood at 14653.19%.
  • As far as peak fluctuations go, Editas Medicine's EBT Margin tumbled by -1320523700bps in 2022, and later surged by 1318396500bps in 2023.
  • Editas Medicine's EBT Margin (Quarter) stood at 332.3% in 2021, then tumbled by -180bps to 929.22% in 2022, then skyrocketed by 97bps to 31.41% in 2023, then plummeted by -372bps to 148.32% in 2024, then plummeted by -124bps to 332.97% in 2025.
  • Its last three reported values are 332.97% in Q3 2025, 1438.71% for Q2 2025, and 1624.37% during Q1 2025.